shutterstock_1839732814_mina_dastjerdi
12 May 2023FeaturesJurisdiction reportsNaomi Pearce, Eliza Jane Saunders and Chris Vindurampulle

Australia: Beware the shifting sands of term extensions

There is no limit to the number of PTEs a pharmaceutical patentee can obtain in Australia. It increasingly common for there to be five to ten (or more) patents extended per medicine.

Under the Patents Act 1990 (the Act), the only relevant subject matter limitation is that the patent must disclose and claim:

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
21 June 2022   Australia’s IP office, IP Australia, and the European Patent Office (EPO) have agreed to continue the patent prosecution highway (PPH) programme, following a successful pilot phase.
Patents
10 August 2021   Allowing an AI as an inventor could benefit the country’s pharma and drug discovery industries, say Richard Hamer, Lauren John and Alexandra Moloney of Allens.